Raytelligence Full Year 2024 Earnings: kr0.008 loss per share (vs kr1.04 loss in FY 2023)

Raytelligence (NGM:RAYTL) Full Year 2024 Results

Key Financial Results

• Revenue: kr774.0k (down 31% from FY 2023).
• Net loss: kr3.31m (loss narrowed by 95% from FY 2023).
• kr0.008 loss per share (improved from kr1.04 loss in FY 2023).

All figures shown in the chart above are for the trailing 12 month (TTM) period

In the last 12 months, the only revenue segment was Patient Monitoring Equipment contributing kr774.0k. Notably, cost of sales worth kr441.0k amounted to 57% of total revenue thereby underscoring the impact on earnings. The largest operating expense was General & Administrative costs, amounting to kr4.02m (108% of total expenses). Over the last 12 months, the company's earnings were enhanced by non-operating gains of kr82.0k. Explore how RAYTL's revenue and expenses shape its earnings.

Raytelligence shares are down 2.2% from a week ago.

Risk Analysis

We don't want to rain on the parade too much, but we did also find 6 warning signs for Raytelligence that you need to be mindful of.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.